# Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female

> **NCT04633330** · NA · UNKNOWN · sponsor: **Shandong University** · enrollment: 60 (estimated)

## Conditions studied

- High Risk Human Papillomavirus Infection
- Low Grade Squamous Intraepithelial Lesion

## Interventions

- **DRUG:** AHCC®capsules
- **DRUG:** Simulation of AHCC®capsules

## Key facts

- **NCT ID:** NCT04633330
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-26
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04633330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04633330, "Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04633330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*